Oxygenta Pharmaceutical Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	21.49	0.02	0.02	0.18	0.72
Short-Term Investments	-	-	-	0.89	0.84
Cash & Short-Term Investments	21.49	0.02	0.02	1.06	1.56
Cash Growth	126311.76%	-	-98.40%	-31.78%	-65.02%
Accounts Receivable	100.28	50.98	73.61	101.6	15.76
Other Receivables	-	44.97	22.7	-	-
Receivables	100.28	95.95	96.31	101.6	15.76
Inventory	294.21	205.13	137.17	117.05	72.83
Prepaid Expenses	-	0.83	0.4	0.24	0.11
Other Current Assets	98.32	7.5	7.17	30.11	5.38
Total Current Assets	514.3	309.43	241.06	250.06	95.64
Property, Plant & Equipment	475.99	398.63	293.58	279.13	203.2
Long-Term Investments	4.74	0.49	0.49	0.49	0.49
Long-Term Accounts Receivable	17.69	10.83	-	3.97	3.68
Long-Term Deferred Tax Assets	174.07	108.01	87.33	-	-
Other Long-Term Assets	10.02	6.81	5.26	4.79	4.55
Total Assets	1,197	834.2	631.92	542.65	311.76
Accounts Payable	487.69	297.94	228.87	237.8	64.59
Accrued Expenses	-	18.75	19.13	33.78	5.23
Short-Term Debt	-	399.41	74.63	49.71	10.86
Current Portion of Long-Term Debt	342.81	7.69	7.69	7.7	-
Other Current Liabilities	30.47	134.68	6.62	-	-
Total Current Liabilities	860.97	858.47	336.95	328.98	80.68
Long-Term Debt	752.86	215.22	490.02	622.53	510.43
Pension & Post-Retirement Benefits	-	8.25	4.8	4.08	2.92
Long-Term Deferred Tax Liabilities	-	-	-	16.59	14.61
Other Long-Term Liabilities	9.84	2.5	1.38	32.47	49.41
Total Liabilities	1,624	1,084	833.15	1,005	658.05
Common Stock	369.84	369.84	334.84	142.01	142.01
Additional Paid-In Capital	-	115.91	96.41	-	-
Retained Earnings	-	-735.63	-638.81	-604.01	-488.3
Comprehensive Income & Other	-796.7	-0.36	6.34	-	-
Shareholders' Equity	-426.87	-250.25	-201.22	-462	-346.29
Total Liabilities & Equity	1,197	834.2	631.92	542.65	311.76
Total Debt	1,096	622.32	572.34	679.94	521.29
Net Cash (Debt)	-1,074	-622.31	-572.32	-678.87	-519.73
Net Cash Per Share	-29.04	-17.31	-17.86	-47.80	-40.78
Filing Date Shares Outstanding	37.86	36.98	33.48	14.2	14.2
Total Common Shares Outstanding	37.86	36.98	33.48	14.2	14.2
Working Capital	-346.67	-549.05	-95.89	-78.92	14.96
Book Value Per Share	-11.27	-6.77	-6.01	-32.53	-24.38
Tangible Book Value	-426.87	-250.25	-201.22	-462	-346.29
Tangible Book Value Per Share	-11.27	-6.77	-6.01	-32.53	-24.38
Land	-	-	1.82	1.82	1.82
Buildings	-	-	78.45	70.43	57.66
Machinery	-	-	425.07	392.04	304.93
Construction In Progress	-	-	-	-	3.43

Source: S&P Global Market Intelligence. Standard template. Financial Sources.